ABSTRACT
Introduction: The implementation of courses related to environmental health in undergraduate curricula favors the formation of physicians more committed to the impact of climate change on health. The aim of the study was to identify the prevalence of environmental health courses in Peruvian medical schools, as well as their comparison with air quality levels for each region of the country.Methods: A descriptive study was carried out. We searched the web page of the National Superintendence of University Higher Education (SUNEDU) of Peru and selected those universities with registered human medicine faculties. We analyzed whether they included in their curriculum a course related to environmental medicine and compared it with the levels of air quality (particulate matter) for each region. Results: Of 41 medical schools included, 26 (63.4%) of them included a course related to environmental health in their curriculum, and 2 (7.7%) of them included it as an optional course. Of the regions with a moderate/bad air quality index, 63% have medical schools with lecture courses on environmental medicine. Conclusions: It is necessary to standardize the methodology, contents and teaching resources, as well as the study of relevant topics such as climate change, in addition to its integration with the other courses of the medical career given the importance of environmental health in the different regions of Peru
Introducción: La implementación de cursos relacionados a la salud ambiental en las currículas de pregrado favorece la formación de médicos más comprometidos con el impacto del cambio climático sobre la salud. El objetivo del estudio fue identificar la prevalencia de cursos lectivos sobre salud ambiental en facultades de medicina del Perú, así como su comparación con los niveles de calidad de aire por cada región del país. Métodos: Se realizó un estudio descriptivo. Se buscó en la página web de la Superintendencia Nacional de Educación Superior Universitaria (SUNEDU) del Perú y se seleccionó aquellas universidades con facultad de medicina humana registradas. Se analizó si estas incluían en su currículo un curso relacionado a medicina ambiental y se comparó con los niveles de calidad de aire (Material particulado) por cada región. Resultados: De 41 facultades de medicina incluidas, 26 (63,4%) de ellas incluyeron en su currículum un curso relacionado a salud ambiental, y 2 (7,7%) de ellas lo incluyeron como un curso opcional. De las regiones con un índice de calidad de aire moderado/malo, el 63% cuentan con facultades de medicina con cursos lectivos sobre medicina ambiental. Conclusiones: Es necesario estandarizar su metodología, contenidos y recursos de enseñanza, así como el estudio de temas relevantes como el cambio climático, además de su integración con los demás cursos de la carrera médica dada la importancia que cobra la salud ambiental en las diferentes regiones del Perú.
Subject(s)
Education, Medical, Undergraduate , Humans , Peru , Education, Medical, Undergraduate/methods , Curriculum , Educational Status , Environmental HealthABSTRACT
Resumen El presente documento analiza la factibilidad de la implementación de los resultados del ensayo clínico SPRINT, la necesidad de replantear las guías de práctica clínica (GPC) para el manejo de la hipertensión arterial y los costos asociados a su aplicabilidad en la práctica diaria. El SPRINT es un ensayo clínico que comparó el control intensivo de la presión arterial sistólica <120 mmHg y <140 mmHg sobre las complicaciones cardiovasculares, generando un gran impacto en el mundo seguido de la publicación de diversos estudios que han abordado desde diversas perspectivas la relevancia, utilidad, aplicabilidad y aspectos controversiales del SPRINT. El logro de la presión arterial meta es uno de los temas más discutidos en las GPC de hipertensión arterial de mayor uso a nivel mundial y latinoamericano. El SPRINT ha generado y generará un gran impacto en las GPC, siendo necesaria la reevaluación de las presiones arteriales meta y su inclusión en las GPC futuras, como ha sido considerado por la guía canadiense 2016 y será considerado en la actualización de la Guía NICE programada para junio. El ensayo SPRINT plantea nuevas evidencias para el manejo de la hipertensión arterial, útil en personas mayores de 50 años, procedentes de poblaciones urbanas, con riesgo cardiovascular definido y sin comorbilidades asociadas. La aplicabilidad del SPRINT en Latinoamérica es limitada por el aumento de costos asociados a la atención de salud integral del paciente hipertenso, la baja cobertura de atención y escasez de programas integrales de atención.
Abstract This paper analyzes the feasibility of the implementation of SPRINT trial results, the need to rethink the clinical practice guidelines(CPG) for the management of arterial hypertension and associated costs with daily practice applicability. SPRINT is a clinical trial comparing systolic blood pressure control <120 mmHg and <140 mmHg over cardiovascular complications, generating a great worldwide impact followed by publication of several studies that addressed relevance, usefulness, applicability and controversial aspects of SPRINT from different perspectives. Achieving blood pressure goals is one of the most discussed issue in widely used hypertension CPG around the world and in Latin American. SPRINT has generated and will generate a great impact on CPG, being necessary the reassessment of blood pressure goals and inclusion in future CPG, as has been considered in 2016 Canadian guideline and will be considered in NICE guideline update scheduled for June. The SPRINT trial raises new evidence for the management of hypertension, useful in people over 50 years, from urban populations, with defined cardiovascular risk without associated comorbidities. The applicability of SPRINT in Latin America is limited by increased costs associated with hypertensive patients’ integrated health care, low care coverage, and lack of integrated care programs.
Subject(s)
Humans , Hypertension/therapy , Randomized Controlled Trials as Topic , Multicenter Studies as Topic , Health Care Costs , Practice Guidelines as Topic , Hypertension/economics , Latin AmericaABSTRACT
This paper analyzes the feasibility of the implementation of SPRINT trial results, the need to rethink the clinical practice guidelines(CPG) for the management of arterial hypertension and associated costs with daily practice applicability. SPRINT is a clinical trial comparing systolic blood pressure control <120mmHg and <140mmHg over cardiovascular complications, generating a great worldwide impact followed by publication of several studies that addressed relevance, usefulness, applicability and controversial aspects of SPRINT from different perspectives. Achieving blood pressure goals is one of the most discussed issue in widely used hypertension CPG around the world and in Latin American. SPRINT has generated and will generate a great impact on CPG, being necessary the reassessment of blood pressure goals and inclusion in future CPG, as has been considered in 2016 Canadian guideline and will be considered in NICE guideline update scheduled for June. The SPRINT trial raises new evidence for the management of hypertension, useful in people over 50 years, from urban populations, with defined cardiovascular risk without associated comorbidities. The applicability of SPRINT in Latin America is limited by increased costs associated with hypertensive patients' integrated health care, low care coverage, and lack of integrated care programs.